中国银河证券首席经济学家、研究院院长章俊11月26日在中国银河证券2026年度策略报告会上表示， 2026年是"十五五"规划的开局之年，全球百年未遇之大变局加速演进，国内经济底层逻辑从土地财政全 面转向新质生产力，人工智能带来科技飞跃的曙光。 来源：上海证券报·中国证券网 瑞银资产管理中国股票主管施斌表示，"今年，创新板块是拉动市场表现的主要助推力，医药、人工智 能、科技等板块领跑股市收益。我们认为，在基本面持续改善的背景下，创新板块将依旧保持稳健增 长。同时，创新增长与高股息价值将继续双线并行。高股息股票在中国低利率环境下仍具吸引力，部分 龙头股息率超过5%。" 11月25日，摩根士丹利中国首席股票策略师王滢发布最新报告，汇总了当前投资者最关注的几大问题。 她表示，自摩根士丹利发布2026年中国股票策略展望报告以来，市场关于股票中长期可持续性的讨论愈 发激烈，这一讨论不仅聚焦中国市场，也涉及全球范围。 MACD金叉信号形成，这些股涨势不错！ 11月26日，30年期国债期货主力合约收跌0.86%。截至收盘，30年期国债期货（TL2603）报收114.290 元，下跌0.990元，跌幅0.86%；10年期国债期 ...

来源：上海证券报·中国证券网 上证报中国证券网讯 11月26日，ETF午间收盘涨跌不一，通信ETF(515880)涨6.64%，通信设备 ETF(159583)涨6.12%，创业板人工智能ETF大成(159242)涨6.06%，航天航空ETF(159208)跌2.23%，航 空航天ETF(159227)跌2.18%，航空航天ETF天弘(159241)跌2.07%。 ...

Market Overview - The three major A-share indices collectively adjusted today, with the Shanghai Composite Index down 0.38%, the Shenzhen Component Index down 0.52%, and the ChiNext Index down 0.74% [1] - The total trading volume in the Shanghai, Shenzhen, and Beijing markets was 12,680 billion yuan, a decrease of 1,864 billion yuan compared to the previous day [1] - Over 2,900 stocks in the market experienced an increase [1] Sector Performance - The sectors with the highest gains included cultivated diamonds, photovoltaic equipment, battery chemicals, gas, pharmaceutical commerce, and non-ferrous metals [1] - The sectors with the largest declines included coal mining and processing, insurance, liquor, AI corpus, computing power hardware, and securities [1] ETF Performance - In the ETF market, Hong Kong automotive ETFs showed strong performance, with gains of 2.38%, 2.35%, and 2.26% for Guangfa Fund, ICBC Credit Suisse Fund, and Huatai-PineBridge Fund respectively [1] - The new energy sector also performed well, with Penghua Fund's Science and Technology New Energy ETF rising by 1.94% [1] - Gold prices continued to rise, with Tianhong Fund's Shanghai Gold ETF increasing by 1.86% [1] - The coal sector saw significant declines, with the coal ETF down 2.56% [1] - The AI hardware sector weakened, with both the communication ETF and communication equipment ETF falling by 2% [1] - Consumer electronics concept stocks weakened, with the consumer electronics ETF down 1.63% [1]

Group 1 - The satellite navigation sector experienced an initial surge, with Shanghai Port Bay achieving two consecutive trading limits, and Aerospace Hongtu rising over 10% [1] - Related ETFs showed positive performance, with the Communication Equipment ETF (159583) increasing by 0.55% and a trading volume of 7.85 million yuan, while the 5G Communication ETF (515050) had a trading volume of 15.10 million yuan [1] - According to Founder Securities, space-based data centers are expected to address AIDC energy bottlenecks due to their low operating costs, high power generation capacity, and rapid deployment speed, making them a key solution in the future [1] Group 2 - Huaxi Securities highlighted that the low-cost, resource-rich, and spacious characteristics of space computing provide a stable long-term profit model for commercial aerospace [1] - The industry is currently transitioning from "sky sensing and ground computing" to "sky computing in the sky," with plans for global coverage of space computing networks as network deployment progresses [1]

Core Viewpoint - The technology sector, particularly in optical modules, optical communication, and communication services, is experiencing a resurgence, with significant gains in related ETFs and stocks driven by positive market developments and policy changes [1] Group 1: Market Performance - The communication equipment ETF (159583) saw an intraday increase of 3.31%, with key stocks like Hongda Electronics and Guangku Technology rising over 5%, and Zhongji Xuchuang and Xinyi Sheng increasing by more than 4% [1] - Over 70% of listed companies in the optical communication sector reported earnings growth in the first three quarters [1] Group 2: Policy Impact - The Chinese government announced specific measures to implement the consensus reached during the China-US Kuala Lumpur economic and trade consultations, including the cessation of anti-circumvention measures on imports of single-mode optical fibers originating from the United States [1] Group 3: Industry Outlook - The demand for computing power is expanding, leading to a favorable environment for the optical communication market, which is expected to transition from "competing for orders" to "ensuring delivery" in the coming year [1] - Leading companies in the sector are anticipated to excel due to their supply chain management capabilities [1] Group 4: Investment Opportunities - The communication equipment ETF (159583) tracks the CSI Communication Equipment Theme Index (931271), with a high proportion of leading optical module and computing hardware companies, reflecting the development trends in these industries [1] - Investors without on-site accounts can explore investment opportunities through linked funds (Class A 021933; Class C 021934) [1]

Group 1: Innovation Drug ETFs Performance - On October 31, innovation drug-themed ETFs collectively surged, with the top ten ETFs all being innovation drug-themed, each rising over 5% [1][2] - The top performers included the Science and Technology Innovation Drug ETFs from Huatai and Guotai, both exceeding 7% gains [2][3] - The Hong Kong Stock Connect Innovation Drug ETFs also showed strong performance, with gains over 5% [2][3] Group 2: Market Activity and Trends - On October 31, 11 ETFs had trading volumes exceeding 10 billion yuan, including several bond ETFs and cross-border ETFs like the Hong Kong Stock Connect Innovation Drug ETF [1][6] - On October 30, several industry ETFs, including securities, Hong Kong innovation drug, and medical ETFs, saw significant net inflows [8][9] - The previous trading day, broad-based ETFs experienced substantial net inflows, with those tracking the CSI 500 seeing over 1.1 billion yuan [8][9] Group 3: Decline in Communication Equipment ETFs - On October 31, communication equipment ETFs and communication ETFs led the decline, both dropping over 5% [4][5] - Specific ETFs such as the 5GETF and semiconductor equipment ETFs also experienced declines exceeding 4% [4][5] Group 4: Investment Opportunities in Innovation Drugs - The investment outlook for innovation drugs remains positive, with potential catalysts in the fourth quarter that could reactivate market sentiment [10] - The biotech sector in China is positioned as a key choice for multinational pharmaceutical companies due to its engineering talent and cost advantages [10] - The trend of domestic brands expanding internationally, particularly in sectors like automotive and innovation drugs, is expected to open up further market opportunities [10]

Market Overview - The A-share market experienced a broad decline, with the Shanghai Composite Index falling by 0.81%, accumulating a 1.85% increase in October and briefly surpassing 4000 points [1] - The Shenzhen Component dropped by 1.14%, with a cumulative decline of 1.1% in October [1] - The ChiNext Index decreased by 2.31%, accumulating a 1.56% decline in October [1] Trading Volume - The total trading volume in the Shanghai, Shenzhen, and Beijing markets was 23,498 billion yuan, a decrease of 1,145 billion yuan compared to the previous day [1] Sector Performance - Over 3,700 stocks rose against the market trend, while the computing hardware industry chain saw a significant pullback, particularly in CPO and memory sectors [1] - The semiconductor, consumer electronics, and rare earth sectors experienced notable declines [1] - AI applications, innovative pharmaceuticals, and large consumer concept stocks showed resilience and performed well [1] ETF Performance - The innovative pharmaceutical sector saw a comprehensive rebound, with the ETF for innovative pharmaceuticals from Huatai-PineBridge and Guotai rising by 7.71% and 7.27%, respectively [1] - Hong Kong's innovative pharmaceutical ETFs also followed suit, with gains exceeding 5% for several funds [1] - The Nikkei 225 index rose by 2.12%, reaching a new historical high, with related ETFs from E Fund and Huaan increasing by 3.39% and 2.94%, respectively [1] Declines in Specific Sectors - The AI hardware sector faced significant setbacks, with communication ETFs and communication equipment ETFs both declining by over 5% [1] - The semiconductor sector also weakened, with semiconductor equipment ETFs from E Fund and the Sci-Tech semiconductor ETF both dropping by 4% [1]

Group 1: Innovation Drug ETFs Performance - On October 31, innovation drug-themed ETFs collectively surged, with the top ten ETFs all being innovation drug-themed, each rising over 5% [1][2] - The top performers included the Science and Technology Innovation Drug ETFs from Huatai and Guotai, both exceeding 7% gains [2][3] - The Hong Kong Stock Connect Innovation Drug ETFs also showed strong performance, with gains over 5% [2][3] Group 2: Market Activity and Fund Flows - On October 31, 11 ETFs had trading volumes exceeding 10 billion yuan, including several bond ETFs and cross-border ETFs like the Hong Kong Stock Connect Innovation Drug ETF [1][6] - On October 30, several industry ETFs, including the Securities ETF and the Hong Kong Stock Connect Innovation Drug ETF, saw significant net inflows [8][9] - The Securities ETF led with a net inflow of 14.04 billion yuan on October 30 [9] Group 3: Communication Equipment ETFs Decline - On October 31, communication equipment ETFs and communication ETFs led the decline, both dropping over 5% [4][5] - Notable declines were observed in the 5GETF and semiconductor equipment ETFs, which fell over 4% [4][5] Group 4: Investment Opportunities in Innovation Drugs - The investment outlook for innovation drugs remains positive, with potential catalysts in the fourth quarter that could reactivate market sentiment [10] - The domestic biotech sector is seen as a key choice for multinational pharmaceutical companies due to its advantages in efficient research and development [10] - The trend of domestic brands expanding internationally, particularly in sectors like automotive and innovation drugs, is expected to open up further market opportunities [10]

Market Overview - The A-share market experienced a collective pullback on October 31, 2025, with the Shanghai Composite Index down by 0.81%, the Shenzhen Component Index down by 1.14%, and the ChiNext Index down by 2.31%. The total trading volume in the Shanghai and Shenzhen markets reached 2,317.8 billion yuan [1]. Innovation Drug Sector - The innovative drug sector saw significant gains, with the top-performing ETFs including the Sci-Tech Innovation Drug ETF managed by Huatai-PB, which rose by 7.71%, and the Sci-Tech Innovation Drug ETF managed by Guotai, which increased by 7.27% [2][3]. - The 2025 ESMO annual meeting, held from October 17 to 21 in Berlin, featured 35 Chinese studies, with 14 presented as formal oral reports, marking a substantial increase from 5 in 2024. The inclusion of 23 studies in the Late-Breaking Abstracts (LBA) category also set a new record [3]. Funding in Innovative Drug Development - From 2015 to 2024, the cumulative financing scale in China's innovative drug sector exceeded 1.23 trillion yuan, providing strong capital support for the industry's explosive growth. Successful research outcomes are expected to attract more funding into innovative drug development, creating a positive feedback loop [4]. Semiconductor Sector - The semiconductor industry in China is undergoing a "collective charge" towards self-sufficiency, driven by external pressures and internal demands. Various regions are launching semiconductor projects, with a focus on vertical integration and filling domestic gaps in key areas such as large silicon wafers and MEMS sensors [6]. ETF Trading Activity - The Short-term Bond ETF (511360) led in trading volume with 40.356 billion yuan, followed by the Hua Bao Tian Yi ETF (211990) with 21.464 billion yuan and the Yin Hua Ri Li ETF (211880) with 20.665 billion yuan [7]. - The 5-Year Local Government Bond ETF (511060) had the highest turnover rate at 212%, indicating strong trading activity in this segment [8]. Upcoming ETF Issuances - Six new ETFs are set to begin fundraising on the upcoming Monday, including the E Fund Hang Seng Automotive ETF and the Southern Hong Kong Stock Dividend ETF, which focus on specific sectors such as automotive and agriculture [9][10].

Group 1 - Lin Hongjun has been appointed as the new general manager of Tianzhi Fund as of October 31, 2025, with a background in several prominent funds [1] - The number of fund managers in the active equity sector managing over 10 billion yuan has increased to 109, up by 34 from the previous quarter [2] - Central Huijin's holdings in ETFs have reached approximately 1.55 trillion yuan, an increase of over 200 billion yuan compared to the previous quarter [3] Group 2 - Fund manager Xie Zhiyu has increased his stake in Shuguang Shuchuang, with his funds holding 2.3496 million shares and 1.5845 million shares respectively as of the end of Q3 [3] - The market experienced a downturn, with the ChiNext index dropping over 2%, and the total trading volume in the Shanghai and Shenzhen markets was 2.32 trillion yuan, a decrease of 103.9 billion yuan from the previous trading day [4] Group 3 - The Chinese innovative drug industry is entering a new phase of global leadership, supported by comprehensive policy backing, transitioning from imitation to original innovation [7] - The newly launched fund "Fuguo Xinghe Mixed" is a mixed securities investment fund managed by Fan Yan, with a performance benchmark based on a combination of various indices [8]